Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human CD200/MOX1/MOX2 ORF/cDNA clone-Adenovirus particle (NM_005944.6)
Cat. No.: vGMAP000585
Pre-made Human CD200/MOX1/MOX2 Adenovirus for CD200 overexpression in-vitro and in-vivo. The CD200 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CD200-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
CD200/MOX1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
MSDS
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000585 | Human CD200 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000585 |
| Gene Name | CD200 |
| Accession Number | NM_005944.6 |
| Gene ID | 4345 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 810 bp |
| Gene Alias | MOX1,MOX2,MRC,OX-2 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGAGAGGCTGGTGATCAGGATGCCCTTCTCTCATCTGTCTACCTACAGCCTGGTTTGGGTCATGGCAGCAGTGGTGCTGTGCACAGCACAAGTGCAAGTGGTGACCCAGGATGAAAGAGAGCAGCTGTACACACCTGCTTCCTTAAAATGCTCTCTGCAAAATGCCCAGGAAGCCCTCATTGTGACATGGCAGAAAAAGAAAGCTGTAAGCCCAGAAAACATGGTCACCTTCAGCGAGAACCATGGGGTGGTGATCCAGCCTGCCTATAAGGACAAGATAAACATTACCCAGCTGGGACTCCAAAACTCAACCATCACCTTCTGGAATATCACCCTGGAGGATGAAGGGTGTTACATGTGTCTCTTCAATACCTTTGGTTTTGGGAAGATCTCAGGAACGGCCTGCCTCACCGTCTATGTACAGCCCATAGTATCCCTTCACTACAAATTCTCTGAAGACCACCTAAATATCACTTGCTCTGCCACTGCCCGCCCAGCCCCCATGGTCTTCTGGAAGGTCCCTCGGTCAGGGATTGAAAATAGTACAGTGACTCTGTCTCACCCAAATGGGACCACGTCTGTTACCAGCATCCTCCATATCAAAGACCCTAAGAATCAGGTGGGGAAGGAGGTGATCTGCCAGGTGCTGCACCTGGGGACTGTGACCGACTTTAAGCAAACCGTCAACAAAGGCTATTGGTTTTCAGTTCCGCTATTGCTAAGCATTGTTTCCCTGGTAATTCTTCTCGTCCTAATCTCAATCTTACTGTACTGGAAACGTCACCGGAATCAGGACCGAGAGCCCTAA |
| ORF Protein Sequence | MERLVIRMPFSHLSTYSLVWVMAAVVLCTAQVQVVTQDEREQLYTPASLKCSLQNAQEALIVTWQKKKAVSPENMVTFSENHGVVIQPAYKDKINITQLGLQNSTITFWNITLEDEGCYMCLFNTFGFGKISGTACLTVYVQPIVSLHYKFSEDHLNITCSATARPAPMVFWKVPRSGIENSTVTLSHPNGTTSVTSILHIKDPKNQVGKEVICQVLHLGTVTDFKQTVNKGYWFSVPLLLSIVSLVILLVLISILLYWKRHRNQDREP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-504 | Pre-Made Samalizumab biosimilar, Whole mAb, Anti-CD200 Antibody: Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody |
| Target Antibody | GM-Tg-g-T81695-Ab | Anti-OX2G/ CD200/ MOX1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T81695-Ag | CD200 VLP (virus-like particle) |
| ORF Viral Vector | pGMLV000200 | Human CD200 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000585 | Human CD200 Adenovirus plasmid |
| ORF Viral Vector | vGMLV000200 | Human CD200 Lentivirus particle |
| ORF Viral Vector | vGMAP000585 | Human CD200 Adenovirus particle |
Target information
| Target ID | GM-T81695 |
| Target Name | CD200 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
4345 |
| Gene ID |
100071509 (Equus caballus), 101096094 (Felis catus), 17470 (Mus musculus), 24560 (Rattus norvegicus) 4345 (Homo sapiens), 534910 (Bos taurus), 607499 (Canis lupus familiaris), 708110 (Macaca mulatta) |
| Gene Symbols & Synonyms | CD200,Cd200,OX2,Mox2,Cspmo2,MRCOX2,MRC,MOX1,MOX2,OX-2 |
| Target Alternative Names | CD200,Cd200,Cspmo2,MOX1,MOX2,MRC,MRCOX2,Mox2,OX-2,OX-2 membrane glycoprotein,OX2 |
| Uniprot Accession |
O54901,P04218,P41217
Additional SwissProt Accessions: O54901,P04218,P41217 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000017925, ENSMUSG00000022661, ENSG00000091972, ENSBTAG00000033319, ENSCAFG00845029323, ENSMMUG00000016076 |
| Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.